SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-032960
Filing Date
2022-05-31
Accepted
2022-05-31 18:25:28
Documents
1
Period of Report
2022-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6448
  Complete submission text file 0001209191-22-032960.txt   8019
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Issuer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PRINCIPIA BIOPHARMA INC. 220 E. GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Thomas Dolca (Reporting) CIK: 0001768239 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37345 | Film No.: 22985117